A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea
Title:
A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea in advanced cancer patients.
Funding Source:
National Health and Medical Research Council
Partners:
Queensland University of Technology
ResearchTeam:
Professor Patsy Yates (Principal Investigator)
Associate Professor Peter Hudson – Director, Centre for Palliative Care
Dr Jennifer Philip – Centre for Palliative Care, St Vincent’s Hospital Melbourne
Professor Janet Hardy
Associate Professor Peter Martin
Professor David Currow
Associate Professor Geoffrey Mitchell
Duration:
5 years
Purpose:
This study aims to test the effectiveness of an intervention which uses available anti-nausea medication specifically targeted to the likely cause of nausea for that individual to reduce the severity and impact of the symptom. It also tests second line medications where nausea is unrelieved.
Method:
This is a randomised controlled trial with approximately 500 patients recruited from seven major health providers, including all patients with nausea related to advanced cancer.
Results:
N/A
